EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 3.0

Diagnosis and Therapeutic Challenges of Drug-Resistant Tuberculosis Infection After Kidney Transplantation: A Rare Case Report

Chang Song, Chun-Yan Zhao, Xue-Wen Huang iD, Chang-Jiang Mo, Hang-Biao Qiang, Xiao-Shi Lin, Zhen-Tao Huang, Zhou-Hua Xie, Qing-Dong Zhu

Infection and Drug Resistance · 2026-02 · Volume 19 · 1-9

DOI: 10.2147/idr.s590648 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Infection and Drug Resistance, 2026-02. Verfasst von Chang Song und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tuberculosis, The Fourth People's Hospital of Nanning, Nanning, Guangxi, 530023, People's Republic of China. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Kidney transplant recipients are at high risk for tuberculosis (TB), particularly drug-resistant forms, due to prolonged immunosuppressive therapy. The diagnosis and treatment of TB in this population pose unique challenges, including infection control, graft protection, and drug interactions. Case Presentation: We report the case of a 28-year-old male kidney transplant recipient was diagnosed with pulmonary TB four months post-transplantation. The patient self-discontinued initial anti-TB therapy after one month, leading to relapse nine months later, with confirmed rifampicin resistant. Following three months of treatment with a second-line regimen including linezolid, he developed disseminated skeletal TB, with drug susceptibility testing indicating linezolid resistance. The treatment was adjusted to an all-oral regimen including isoniazid, moxifloxacin, clofazimine, cycloserine, and bedaquiline, resulting in significant clinical and radiological improvement.

Discussion

In the present case, the patient's non-adherence to the medication regimen resulted in initial treatment failure. Against the backdrop of immunosuppression, rifampicin resistance emerged rapidly. Although the subsequent linezolid-containing regimen was administered for a short duration, it likely triggered ribosomal target mutations-leading to linezolid resistance and hematogenous dissemination to the bone-driven by both drug selection pressure and the history of irregular treatment. Confronted with dual resistance and disseminated disease, the therapeutic strategy pivoted to a bedaquiline-based regimen. This shift highlights the clinical management art of finely balancing treatment efficacy with the risk of rejection through the optimized adjustment of immunosuppressants guided by therapeutic drug monitoring.

Conclusion

The management of drug-resistant tuberculosis in kidney transplant recipients necessitates a flexible and comprehensive strategy. This encompasses early clinical suspicion, the prompt performance of molecular and phenotypic drug susceptibility testing to guide therapeutic decisions, rigorous management of treatment adherence, and the real-time adjustment of therapeutic regimens based on evolving resistance profiles and clinical responses. Multidisciplinary collaboration is essential for balancing anti-tuberculosis efficacy with graft survival. Although novel agents such as bedaquiline offer promising options for salvage therapy, their administration in transplant recipients requires intensified monitoring for drug-drug interactions and adverse events.

Schlagwörter

Stichwörter der Autor:innen

bedaquilinedrug-resistant tuberculosiskidney transplantation

Autor:innen und Institutionen

  • Department of Tuberculosis, The Fourth People's Hospital of Nanning, Nanning, Guangxi, 530023, People's Republic of China.
  • Clinical Medical School, Guangxi Medical University, Nanning, Guangxi, 530021, People's Republic of China.

ORCID-Profile: Xue-Wen Huang

Zitieren

APA

Song, C., Zhao, C. Y., Huang, X. W., Mo, C. J., Qiang, H. B., Lin, X. S., Huang, Z. T., Xie, Z. H., & Zhu, Q. D. (2026). Diagnosis and Therapeutic Challenges of Drug-Resistant Tuberculosis Infection After Kidney Transplantation: A Rare Case Report. Infection and Drug Resistance, Volume 19, 1-9. https://doi.org/10.2147/idr.s590648

Vancouver

Song C, Zhao CY, Huang XW, Mo CJ, Qiang HB, Lin XS, et al. Diagnosis and Therapeutic Challenges of Drug-Resistant Tuberculosis Infection After Kidney Transplantation: A Rare Case Report. Infection and Drug Resistance. 2026;Volume 19:1-9. doi:10.2147/idr.s590648

BibTeX
@article{Song2026,
  author = {Song, Chang and Zhao, Chun-Yan and Huang, Xue-Wen and Mo, Chang-Jiang and Qiang, Hang-Biao and Lin, Xiao-Shi and Huang, Zhen-Tao and Xie, Zhou-Hua and Zhu, Qing-Dong},
  title = {Diagnosis and Therapeutic Challenges of Drug-Resistant Tuberculosis Infection After Kidney Transplantation: A Rare Case Report},
  journal = {Infection and Drug Resistance},
  year = {2026},
  volume = {Volume 19},
  pages = {1--9},
  doi = {10.2147/idr.s590648}
}
Kostenlos starten →